Conversations in Science With the Disruptors Leading the Way

Partnering With bit.bio for Translational Drug Development

Through a strategic partnership with bit.bio, Charles River provides clients access to a broadening bank of authentic human cells for use in target discovery, validation, and screening services. In drug discovery and safety, bit.bio’s unique ability to generate reprogrammable human cells at scale enables the development of therapies with a higher success rate among patients.